Partnership deals - Tx for the inputs. I'll put together a brief list of the various deals to be updated as items come in. But note that there are too many factors at play to record them all in a MB. So the ones I'll capture will be: upfront, royalty, cash in bank at time of deal, maturity of drug (e.g. randomized data or not), approximate market size of indications in trials (scaled 1 to 4), competition in indication (scaled - 1 to 3).